Company
Headquarters: Cotia, SP, Brazil
Employees: 1,400
CEO: Mr. Marcelo Rodolfo Hahn
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Blau Farmacêutica S.A., a pharmaceutical company, engages in the manufacture, development, and commercialization of private label drugs in Brazil, Colombia, Uruguay, Chile, and internationally. It operates through Institutional and Retail segments. The company's medications cover various therapeutic classes, such as immunology, hematology, oncology, nephrology, specialties, and antibiotics. It offers biological drugs; oral and injectable drugs for treating cancer; specialized treatments for infectious diseases; and prescription and non-prescription over-the-counter drugs, including dermo-medicines, condoms, and others for retail and non-retail markets. The company's products also comprise uterine stimulator, antibiotics, feminine health care, biopharmaceuticals, essential hospital products, antivirals and antiretrovirals, biosimilars, acid pump inhibitor, hemoderivados, antithrombotic, and trombolíticos. It serves public and private hospitals, and clinics; and pharmaceutical retail channels. The company was incorporated in 1987 and is headquartered in Cotia, Brazil.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Blau Farmacêutica SA has the following listings and related stock indices.
Stock: Bovespa: BLAU3 wb_incandescent